Biotech

All Articles

F 2G increases $100M for 2nd attempt to obtain brand new antifungal to market

.After F2G's first try to acquire a new course of antifungal to market was actually wrecked by the F...

Moderna targets $1.1 B in R&ampD costs cuts, drops 5 systems among profitability tensions

.Moderna has actually promised to reduce R&ampD costs by $1.1 billion by 2027. The decision to retra...

Sanofi's $80M bet on Fulcrum dystrophy drug ends in period 3 go under

.Merely four months after Sanofi bet $80 thousand in upfront money on Fulcrum Therapeutics' losmapim...

Oncternal equity sinks 60% surrounded by layoffs, trial discontinuations

.Cancer business Oncternal Therapies is folding all its scientific tests and laying off workers, swi...

Roche is actually supporting out hopes that its own injectable weight problems prospect might inevitably show 25% fat burning in late-stage test

.Roche is actually storing out hopes that its injectable obesity prospect can at some point illustra...

Novo Nordisk hails 'remarkable' weight management lead for dual-acting oral drug in early test

.Novo Nordisk has actually elevated the lid on a phase 1 trial of its oral amylin and GLP-1 receptor...

AbbVie files suit BeiGene over blood cancer medicine secret method

.Only a few short full weeks after succeeding an FDA Fast Track tag for its own investigational BTK ...

Lilly delivers one-two blow along with 2nd tranche of positive data on weekly the hormone insulin candidate

.Quickly after a positive data reduce for Eli Lilly's efsitora alfa, the Indianapolis-based provider...

BridgeBio cuts gene therapy spending plan as scientific information let down

.BridgeBio Pharma is actually slashing its own genetics treatment budget as well as drawing back fro...

GSK gives up HSV injection hopes after phase 2 stop working, resigning ethnicity to Moderna, BioNTech

.GSK's attempt to cultivate the very first vaccine for genital herpes simplex infection (HSV) has en...